QuidelOrtho Corp. Stock
Price
Target price
€27.40
€27.40
-5.220%
-1.4
-5.220%
€51.36
04.06.25 / Tradegate
WKN: A3DNGX / Symbol: QDEL / Name: QuidelOrtho / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
QuidelOrtho Corp. Stock
QuidelOrtho Corp. took a tumble today and lost -€1.400 (-5.220%).
We see a rather positive sentiment for QuidelOrtho Corp. with 7 Buy predictions and 1 Sell predictions.
With a target price of 51 € there is a hugely positive potential of 86.13% for QuidelOrtho Corp. compared to the current price of 27.4 €.
Our community identified positive and negative aspects for QuidelOrtho Corp. stock for the coming years. 1 users see the criterium "Innovation" as a plus for the QuidelOrtho Corp. stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of QuidelOrtho Corp. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
S********** s********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of QuidelOrtho Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| QuidelOrtho Corp. | -5.220% | 1.481% | 11.382% | -31.156% | -34.762% | -67.350% | -80.000% |
| Veeva Systems A | -0.320% | 1.623% | 22.266% | 47.251% | 23.228% | 41.581% | 39.359% |
| Thermo Fisher Scientific Inc. | 1.340% | -0.550% | -1.426% | -33.800% | -29.378% | -32.157% | 12.416% |
| Waters Corp. | 1.300% | -1.465% | 3.791% | 9.561% | -12.992% | 1.326% | 72.849% |
Comments
QuidelOrtho Co. (NASDAQ: QDEL) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $44.00 price target on the stock.
Show more
Ratings data for QDEL provided by MarketBeat
QuidelOrtho Co. (NASDAQ: QDEL) had its price target lowered by analysts at JPMorgan Chase & Co. from $38.00 to $25.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for QDEL provided by MarketBeat
QuidelOrtho Co. (NASDAQ: QDEL) had its price target lowered by analysts at Royal Bank of Canada from $64.00 to $61.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for QDEL provided by MarketBeat
News
QuidelOrtho to Participate in Upcoming Investor Conferences
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine
QuidelOrtho Reports First Quarter 2025 Financial Results
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs, and
QuidelOrtho to Report First Quarter 2025 Financial Results
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company”) or (“QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs and